JP2024539623A - R-ケタミン塩及びその使用方法 - Google Patents
R-ケタミン塩及びその使用方法 Download PDFInfo
- Publication number
- JP2024539623A JP2024539623A JP2024522124A JP2024522124A JP2024539623A JP 2024539623 A JP2024539623 A JP 2024539623A JP 2024522124 A JP2024522124 A JP 2024522124A JP 2024522124 A JP2024522124 A JP 2024522124A JP 2024539623 A JP2024539623 A JP 2024539623A
- Authority
- JP
- Japan
- Prior art keywords
- ketamine
- tartrate
- radiation
- pxrd
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/06—Oxalic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/10—Succinic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163254878P | 2021-10-12 | 2021-10-12 | |
| US63/254,878 | 2021-10-12 | ||
| PCT/US2022/046412 WO2023064363A1 (en) | 2021-10-12 | 2022-10-12 | R-ketamine salts and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539623A true JP2024539623A (ja) | 2024-10-29 |
| JP2024539623A5 JP2024539623A5 (cg-RX-API-DMAC10.html) | 2025-10-21 |
Family
ID=84331621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522124A Pending JP2024539623A (ja) | 2021-10-12 | 2022-10-12 | R-ケタミン塩及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240336556A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4416126A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024539623A (cg-RX-API-DMAC10.html) |
| CN (1) | CN118647595A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3234818A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL312041A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024004478A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023064363A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3043785T3 (da) | 2013-09-13 | 2021-11-15 | Univ Chiba Nat Univ Corp | Anvendelse af r-ketamin og salt deraf som lægemidler |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011115069A1 (ja) * | 2010-03-19 | 2011-09-22 | 第一三共株式会社 | 結晶の網羅的探索 |
| JP2015078181A (ja) * | 2013-09-13 | 2015-04-23 | 国立大学法人 千葉大学 | R−ケタミンおよびその塩の医薬品としての応用 |
| WO2020194087A2 (en) * | 2019-03-25 | 2020-10-01 | Douglas Pharmaceuticals Ltd. | Extended release pharmaceutical formulation |
| WO2020232274A1 (en) * | 2019-05-15 | 2020-11-19 | Bexson Biomedical, Inc. | Ketamine formulation for subcutaneous injection |
| WO2021037960A1 (en) * | 2019-08-30 | 2021-03-04 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
| JP2021523228A (ja) * | 2018-05-04 | 2021-09-02 | パーセプション ニューロサイエンス,インコーポレイティド | 物質乱用の治療方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1444041A2 (en) | 2001-09-21 | 2004-08-11 | Solvias AG | Sealing system with flow channels |
| WO2019065900A1 (ja) | 2017-09-27 | 2019-04-04 | 国立大学法人千葉大学 | 神経変性疾患あるいは認知機能障害の予防または治療剤としてのr-ケタミンおよびその誘導体 |
| WO2019160057A1 (ja) | 2018-02-15 | 2019-08-22 | 国立大学法人千葉大学 | 炎症性疾患若しくは骨疾患の予防又は治療剤及び医薬組成物 |
| US20220110889A1 (en) | 2018-12-27 | 2022-04-14 | National University Corporation Chiba University | R-ketamine and derivative thereof as prophylactic or therapeutic agent for neurodevelopmental disorder |
-
2022
- 2022-10-12 US US18/700,013 patent/US20240336556A1/en active Pending
- 2022-10-12 JP JP2024522124A patent/JP2024539623A/ja active Pending
- 2022-10-12 MX MX2024004478A patent/MX2024004478A/es unknown
- 2022-10-12 WO PCT/US2022/046412 patent/WO2023064363A1/en not_active Ceased
- 2022-10-12 CA CA3234818A patent/CA3234818A1/en active Pending
- 2022-10-12 EP EP22802347.9A patent/EP4416126A1/en active Pending
- 2022-10-12 CN CN202280081833.8A patent/CN118647595A/zh active Pending
- 2022-10-12 IL IL312041A patent/IL312041A/en unknown
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011115069A1 (ja) * | 2010-03-19 | 2011-09-22 | 第一三共株式会社 | 結晶の網羅的探索 |
| JP2015078181A (ja) * | 2013-09-13 | 2015-04-23 | 国立大学法人 千葉大学 | R−ケタミンおよびその塩の医薬品としての応用 |
| JP2021523228A (ja) * | 2018-05-04 | 2021-09-02 | パーセプション ニューロサイエンス,インコーポレイティド | 物質乱用の治療方法 |
| WO2020194087A2 (en) * | 2019-03-25 | 2020-10-01 | Douglas Pharmaceuticals Ltd. | Extended release pharmaceutical formulation |
| WO2020232274A1 (en) * | 2019-05-15 | 2020-11-19 | Bexson Biomedical, Inc. | Ketamine formulation for subcutaneous injection |
| WO2021037960A1 (en) * | 2019-08-30 | 2021-03-04 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
Non-Patent Citations (4)
| Title |
|---|
| 山野光久: ""医薬品のプロセス研究における結晶多形現象への取り組み"", 有機合成化学協会誌, vol. 65, no. 9, JPN6010003277, 1 September 2007 (2007-09-01), pages 907 - 69, ISSN: 0005903834 * |
| 川口洋子,外2名: ""医薬品と結晶多形"", 生活工学研究, vol. 第4巻第 2号, JPN6014015069, 2002, pages 310 - 317, ISSN: 0005903833 * |
| 平山 令明 編, 有機化合物結晶作製ハンドブック −原理とノウハウ−, JPN6011053065, 2008, pages 57 - 84, ISSN: 0005903832 * |
| 精神経誌(2020)122巻6号, JPN6026027710, pages 473 - 480, ISSN: 0005903835 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2024004478A (es) | 2024-07-01 |
| US20240336556A1 (en) | 2024-10-10 |
| CA3234818A1 (en) | 2023-04-20 |
| CN118647595A (zh) | 2024-09-13 |
| WO2023064363A9 (en) | 2024-02-15 |
| WO2023064363A1 (en) | 2023-04-20 |
| EP4416126A1 (en) | 2024-08-21 |
| IL312041A (en) | 2024-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3779682B2 (ja) | 5,8,14−トリアザテトラシクロ[10.3.1.02,11.04,9]−ヘキサデカ−2(11),3,5,7,9−ペンタンの酒石酸塩及びその医薬組成物 | |
| TW202409008A (zh) | 奧比特拉(obicetrapib)鹽及彼等之製造方法與中間體 | |
| TW200526595A (en) | Chemical compounds | |
| CN104918937A (zh) | 曲美替尼及其溶剂化物的晶型、其制备方法、含有它们的药物组合物及其用途 | |
| JP6816036B2 (ja) | ヒストン脱アセチル化阻害剤の結晶形態 | |
| WO2023064363A9 (en) | R-ketamine salts and methods of use thereof | |
| JP2025524904A (ja) | ダプロデュスタットおよびその共結晶を調整するための方法 | |
| CN110582279B (zh) | 2-(6-甲基-吡啶-2-基)-3-基-[6-酰胺基-喹啉-4-基]-5,6-二氢-4H-吡咯并[1,2-b]吡唑的共晶,其制备方法和药物组合物 | |
| DK2729460T3 (en) | Crystalline solvates of 6- (piperidin-4-yloxy) -2H-isoquinolin-1-one hydrochloride | |
| TWI810338B (zh) | Lta4h抑制劑的晶型 | |
| AU2012283277B2 (en) | Polymorphs of 6-(piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride | |
| CN115448895B (zh) | 一种沃替西汀前药的晶型、其制备方法和应用 | |
| JP7727855B2 (ja) | 芳香環誘導体の結晶及びその調製方法と使用 | |
| WO2019099761A1 (en) | Solid state forms of elafibranor | |
| HK40118106A (en) | Salts of obicetrapib and processes for their manufacture and intermediates thereof | |
| EP3976598A1 (en) | Selective histamine h3 antagonist acid addition salts and process for the preparation thereof | |
| NZ620864B2 (en) | Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride | |
| HK1192546B (en) | Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride | |
| WO2013181384A1 (en) | Solid state forms of aleglitazar sodium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251010 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251010 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260707 |